A Multidrug-resistant Engineered CAR T Cell for Allogeneic Combination Immunotherapy

The adoptive transfer of chimeric antigen receptor (CAR) T cell represents a highly promising strategy to fight against multiple cancers. The clinical outcome of such therapies is intimately linked to the ability of effector cells to engraft, proliferate, and specifically kill tumor cells within pat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Ther
Autors principals: Valton, Julien, Guyot, Valérie, Marechal, Alan, Filhol, Jean-Marie, Juillerat, Alexandre, Duclert, Aymeric, Duchateau, Philippe, Poirot, Laurent
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2015
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4817890/
https://ncbi.nlm.nih.gov/pubmed/26061646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2015.104
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars